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Abstract: The objective of this study was to encapsulate iron and chromium into novel nanoparticles
formulated using chitosan (CS), dextran sulfate (DS) and whey protein isolate (WPI) for oral
drug delivery. Empty and loaded CS-DS nanoparticles were prepared via complex coacervation
whilst whey protein nanocarriers were produced by a modified thermal processing method using
chitosan. The physiochemical properties of the particles were characterized to determine the effects
of formulation variables, including biopolymer ratio on particle size and zeta potential. Permeability
studies were also undertaken on the most stable whey protein–iron nanoparticles by measuring Caco-2
ferritin formation. A particle size analysis revealed that the majority of samples were sub-micron sized,
ranging from 420–2400 nm for CS-DS particles and 220–1000 nm for WPI-CS samples. As expected,
a higher chitosan concentration conferred a 17% more positive zeta potential on chromium-entrapped
WPI nanoparticles, whilst a higher dextran volume decreased the size of CS-DS nanoparticles by
32%. The addition of iron also caused a significant increase in size for all samples, as seen where the
loaded WPI samples were 296 nm larger than the empty particles. Caco-2 iron absorption revealed
that one formulation, which had the lowest particle size (226 ± 10 nm), caused a 64% greater iron
absorption compared to the ferrous sulfate standard. This study describes, for the first time, the novel
design of chromium- and iron-entrapped nanoparticles, which could act as novel systems for oral
drug delivery.
Keywords: iron; chromium; whey protein isolate; nanoparticles; oral drug delivery
1. Introduction
Iron and chromium have major roles in the metabolism and oxygen exchange processes [1].
Chromium is a trace element that has received a significant interest in recent years. It aids in the
metabolism of carbohydrates and is thought to impair glucose tolerance in those with chromium
deficiencies. This can lead to the development of maturity-onset diabetes-a chronic condition costing the
national health service (NHS) over nine billion Pounds sterling annually [2,3]. Chromium supplements
can be used to prevent insulin resistance and may be seen in the future as a cost effective strategy to
reduce the onset of type 2 diabetes [4]. Iron is an essential mineral that plays a vital role in oxygen
transport and DNA replication [5]. Almost 20% of the world’s population is iron deficient—a condition
that is prevalent in most countries [6]. Iron is lost from the body through the natural shedding of skin,
during pregnancy and heavy menstruation but cannot be synthesized in vivo [7]. Iron is also poorly
absorbed from dietary sources meaning that supplementation may be needed to maintain healthy
levels. In previous studies, iron-entrapped nanoparticles were formulated using ascorbic acid which
augments the absorption of dietary non-haem iron by reducing ferric iron to the bioavailable ferrous
form [8–10].
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Nanoparticles are defined as solid colloidal structures ranging in size from 1 to 1000 nm. They can
be formed of natural polymers such as chitosan and have a number of advantages including enhancing
the stability of drugs, increasing encapsulation efficiency and having better uptake in the small intestine.
This is because nanoparticles can permeate enterocyte membranes easier than microparticles and
can facilitate the controlled release of the encapsulated drug [11,12]. These qualities are of particular
importance for this study because chromium is poorly absorbed (<2%) [13]. Therefore, nanoparticles
were formulated because they can improve drug bioavailability and reduce toxicity whilst maintaining
therapeutic effects [14].
Biopolymers are naturally abundant polymers and possess a broad range of attributes which can
be used to optimize the properties of nanoparticles. In this study, chitosan (CS), dextran sulfate (DS)
and whey protein isolate (WPI) were chosen due to them being cost effective and generally recognized
as safe (GRAS) [15]. CS is a polysaccharide produced from the exoskeleton of crustaceans by the partial
deacetylation of chitin [16]. It is composed of repeating glucosamine units and is a biodegradable and
pharmaceutically acceptable excipient (Figure 1). CS has a pKa of 6.5 and possesses a high ratio of
amino groups that undergo protonation in acidic conditions, making it soluble in water (Figure 1) [17].
It has mucoadhesive properties and can complex with chromium to produce nanoparticles. DS is
a polyanionic polymer which possesses negatively charged sulfate groups, dictating its ability to form
stable coacervates with CS [18]. It is highly hydrophilic and has been used to control the release of
drugs such as doxorubicin [19]. Complex coacervation was chosen as opposed to ionic gelation because
the nanoparticles have enhanced mechanical strength and stability than those traditionally produced
using CS and sodium triphosphate [20].
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Whey protein is a by-product of the cheese manufacturing process and consists of globular 
proteins, mainly β-lactoglobulin. It has excellent gelation properties and is widely used by athletes 
to stimulate muscle growth. Hence, it can work synergistically with chromium, which is suggested it 
can increase muscle mass, to improve nutritional health and athletic performance [21]. Therefore, 
chromium-entrapped nanoparticles were produced using whey protein isolate through thermal 
processing. Y. Chen was the first to fabricate and entrap an arginine-rich hexapeptide into CS-DS 
nanoparticles [22]. This increased the popularity of biopolymer-based nanoparticle research and led 
to further developments in the field such as the encapsulation of insulin into CS-based nanoparticles 
[23,24]. 
The aim of this study was to build on previous research by fabricating four types of novel 
chromium- and iron-entrapped nanoparticles using different ratios of biopolymers for oral drug 
delivery. The properties of the nanoparticles such as size, charge and stability were then assessed to 
find the optimum formulations. Permeability studies were also performed using Caco-2 cells to 
determine the differences in iron absorption between the formulations. 
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2. Materials and Methods
2.1. Materials
Low and medium molecular weight chitosan (75% deacetylated, 50/190 kDa), dextran sulfate
(190 kDa), chromium (III) chloride hydrate (96%), acetic acid and ferrous sulfate heptahydrate were
purchased from Sigma-Aldrich Co. (Dorset, UK). Unflavored whey protein isolate was obtained from
Davisco Foods International Inc. (Eden Prairie, MN, USA). Sodium hydroxide pellets were purchased
from VWR international (Philadelphia, PA, USA). All nanosuspensions were prepared using deionized
water. Caco-2-cells (HTB-37) were obtained from ATCC (Manassas, VA, USA). Ferritin ELISA kit
(Catalog Number: S22) was purchased from Ramco (Chichester, UK) and Pierce BCA protein assay kit
was from Thermo Fisher Scientific (Cramlington, Northumberland, UK). Permeability studies were
undertaken using Milli-Q water.
2.2. Preparation of the Nanoparticles
2.2.1. Preparation of CS–DS Nanoparticles
Empty CS–DS nanoparticles were prepared by complex coacervation method with some
modification [19]. To study the effects of CS:DS ratio on particle properties, 0.1% (w/v) chitosan
and dextran solutions were prepared. First 200 mg low molecular weight chitosan was dissolved
in 0.175% (v/v) acetic acid whilst 200 mg dextran was dissolved in deionized water. Nanoparticles
formed spontaneously when 10 mL chitosan was added to various volumes of dextran (Table 1) whilst
magnetically stirring (300 rpm) for 15 min at room temperature. Chromium-entrapped nanoparticles
were formulated by adding 0.1% (w/v) chromium hydrate to different volumes of 0.1% dextran solution.
In total, 10 mL chitosan was then mixed with the chromium-dextran solution under magnetic stirring to
form the nanoparticles. Iron-entrapped nanoparticles were produced in a similar fashion where ferrous
sulfate was substituted for chromium. Additional formulations were also prepared using low molecular
weight chitosan (LMW CS) and medium molecular weight chitosan (MMW CS) for all samples. Empty
preparations were coded: LMW CS and MMW CS whilst chromium and iron-entrapped samples were
called: LMW CS-Cr, MMW CS-Cr, LMW CS-Fe and MMW CS-Fe.
Table 1. Composition of chitosan–dextran sulfate (CS-DS) nanoparticle formulations (not determined (ND)).
Type of
Nanoparticle
CS:DS
Ratio
Chitosan
Volume (mL)
Dextran
Volume (mL)
Chromium
Hydrate (mg)
Ferrous
Sulfate (mg)
Loading
Efficiency (%)
empty 4:1 10 2.5 - - -
empty 4:2 10 5.0 - - -
empty 4:3 10 7.5 - - -
Cr entrapped 4:1 10 2.5 12.5 - ND
Cr entrapped 4:2 10 5.0 15.0 - ND
Cr entrapped 4:3 10 7.5 17.5 - ND
Fe entrapped 4:1 10 2.5 - 12.5 13 ± 2.3
Fe entrapped 4:2 10 5.0 - 15.0 21 ± 4.5
Fe entrapped 4:3 10 7.5 - 17.5 47 ± 5.2
2.2.2. Preparation of Whey Protein-Chitosan Nanoparticles
Empty nanoparticles were produced using an adapted method developed by Giroux et al. [25].
First 2.5% (w/v) whey protein isolate solution was prepared by dispersing 2 g WPI in 80 mL deionized
water. This was magnetically stirred at room temperature for 2 h to ensure complete dissolution of the
WPI powder. Next, 0.1% (w/v) low molecular weight (LMW) chitosan solution was added dropwise to
various volumes of the WPI solution whilst stirring at room temperature (Table 2). The sample was
then heat-treated at 85 ◦C for 20 min and left to cool at room temperature for 15 min whilst magnetically
stirring (~300 rpm). The pH was then adjusted to 7.5 using 10 mM NaOH. The same method was
undertaken using medium MW chitosan.
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Table 2. Composition of empty and chromium-loaded whey protein isolate (WPI)-CS
nanoparticle formulations.
Sample WPI:CS Ratio Whey Protein (mL) Chitosan (mL) Chromium Hydrate (mg)
empty 50:1 10.0 5.0 -
empty 125:1 12.5 2.5 -
empty 350:1 14.0 1.0 -
Cr loaded 50:1 10.0 5.0 5
Cr loaded 125:1 12.5 2.5 5
Cr loaded 350:1 14.0 1.0 5
Chromium-entrapped nanoparticles were produced using a similar procedure. First 5 mg
chromium hydrate was fully dissolved into 2.5% WPI solution. Then 0.1% chitosan was added
dropwise whilst stirring. The temperature was then increased to 85 ◦C and the pH adjusted.
Iron-entrapped nanoparticles were produced in a similar way to that stated above for chromium.
Previous studies were used to determine the masses of iron and ascorbic acid to use [26,27]. These studies
stated that an elemental iron to ascorbic acid ratio of 1:5 was required to sufficiently increase iron
absorption. Therefore, since 10 mg ferrous sulfate contained 2 mg elemental iron, 10 mg ascorbic acid
was used (Table 3). These were both dissolved in varying volumes of WPI solution following the same
method shown above with a final iron concentration of 2.3 mM.
Table 3. Composition of iron loaded WPI-CS nanoparticle formulations.
WPI:CS Ratio Whey Protein (mL) Chitosan (mL) Ferrous Sulfate (mg) Ascorbic Acid (mg) Loading Efficiency (%)
50:1 10.0 5.0 10 10 29 ± 4.3
125:1 12.5 2.5 10 10 38 ± 4.1
350:1 14.0 1.0 10 10 54 ± 3.5
Additional formulations were produced for chromium and iron WPI-CS nanoparticles using 0.1%
(w/v) medium MW chitosan (MMW CS-Cr, MMW CS-Fe) and 0.2% (w/v) low MW chitosan (0.2% LMW
CS-Cr, 0.2% LMW CS-Fe) at each ratio. These were prepared using the same quantities and volumes as
seen in Tables 2 and 3.
2.3. Characterization of the Nanoparticles
2.3.1. Particle Size Analysis
Particle size was determined using dynamic light scattering (Zeta Plus analyzer, Brookhaven
instruments, Holtsvilleg, Suffolk County, NY, USA). CS-DS nanoparticles were diluted appropriately
with deionized water and sonicated (Fisher brand) at 80 kHz (pulse mode) for 1 min before measurement
to prevent particle aggregation. WPI-CS nanoparticles were diluted in the same manner before analysis
to avoid multiple scattering. All measurements were carried out at room temperature with each result
being reported as the mean of 10 runs.
2.3.2. Zeta Potential Measurements
Zeta potential analysis was undertaken using electrophoretic light scattering (Zetasizer nanoseries,
Malvern Instruments Ltd., Malvern, UK). Every sample was diluted to the same extent as in size analysis
using deionized water before measurement. All results were recorded as the mean of three repeats.
2.3.3. Transmission Electron Microscopy (TEM)
The morphology of the nanoparticles was observed with a Philips Tecnai-12 FEI Transmission
Electron Microscope (TEM) using an accelerating voltage of 120 kV. The TEM samples were prepared
by depositing a drop of suspension on a carbon-coated copper grid and evaporating the liquid for
5–10 min prior to examination in the microscope.
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2.4. Caco-2 Cell Iron Absorption
Iron absorption studies were undertaking using a method published by Zariwala et al. [8].
Four WPI-CS iron samples (which were the most physically stable over time) were assessed along
with a ferrous sulfate standard. The four iron samples were—350:1 LMW CS-Fe, 350:1 MMW CS-Fe,
175:1 LMW CS-Fe and 125:1 LMW CS-Fe.
Caco-2 cells were seeded onto a 6-well plate with an initial seeding density of 5 × 104 cells/cm2.
Permeability studies commenced on day 13 post seeding so that the cells expressed characteristics of
a fully matured enterocyte lining. First, the growth media was removed, and the cells were washed
with wash solution (140 mM NaCl, 5 mM KCl, 10 mM piperazine-N,N′-bis (2-ethanesulfonic acid)
buffer, pH 6.7, 37 ◦C). They were then incubated in serum-free Minimum Essential Media (MEM) for
24 h. On day 14, test media was prepared by adding 1 M NaOH to 250 mL serum free MEM until
a pH 5.8 solution was obtained. This pH was chosen due to it mimicking the pH of the duodenum.
The media was then filter sterilized (0.2 µm pore size) and aliquoted into centrifuge tubes. Next, 226 µL
of each nanoparticle sample was added into the different tubes containing test media so that a final
elemental iron concentration of 20 µM was achieved. This iron concentration was chosen due to it
being the optimum conditions for the expression of divalent metal transporters in Caco-2 cells [26].
This meant that slight changes in iron absorption between the samples could be detected [8]. The cells
were washed with wash solution before test media was added in duplicate to a 6-well plate. The plate
was then incubated for 2 h at 37 ◦C in a rotary shaker (Thermo Scientific 4450, Waltham, Massachusetts,
United States) at 6 rpm. Growth media (serum free MEM, pH 5.8) was then added and the cells
were incubated for 24 h. After this period, removal solution (5 µM sodium hydrosulfite and 1 µM
bathophenanthroline disulfonic acid) was added to remove surface bound iron. Cell lysis was then
undertaken by adding 350 µL lysis buffer (50 mM NaOH, 10 µL protease inhibitor cocktail, 1 µL
benzonase) to each well. The plate was then incubated at 4 ◦C on a plate rocker (8 rpm) for 25 min.
A cell scraper was used to collect cell lysate which was pipetted into vials. Each lysate was then passed
six times through a 1 mL syringe (25G needle) to reduce their viscosity.
2.5. Iron Absorption Analysis and Determination of Loading Efficiency
The total ferritin concentration was determined using a ferritin enzyme-linked immunosorbent
assay. First, 8 standards (0–200 ng/mL) were produced using the kit diluent. In total, 30 µL of each
standard and sample was pipetted into duplicate wells of a 96-well plate and 200 µL conjugated
antihuman ferritin was then added into each well. The plate was incubated in a rotary shaker at 37 ◦C
for 2 h after which 200 µL substrate solution was added into each well. After a further incubation period
of 30 min at room temperature, 100 µL potassium ferricyanide was added to every well. A microplate
reader (VersaMax, San Jose, CA, USA) was then used to measure the absorbance at 490 and 630 nm.
The total protein concentration was determined using a bicinchoninic acid assay. Pre-diluted
bovine serum albumin was used as the standards. In total, 25 µL of the standards and samples
were pipetted into duplicate wells. Working reagent was prepared and 200 µL added per well.
After incubation (30 min, 37 ◦C) the absorbance was then read at 562 nm. These results were then
used to standardize the ferritin concentration to calculate iron absorption. The loading efficiency of
the nanoparticles (Tables 1 and 3) was indirectly determined by preparing freeze dried samples of
nanoparticles which were dissolved in in aqueous acetic acid solution (1% v/v) and the solutions were
assayed for drug content using same essay above. The entrapment efficiency (%) was determined
using the following equation:
Entrapment efficiency (%) = (weight of drug in nanoparticles)/(weight of initially used drug) × 100 (1)
2.6. Statistical Analysis
Particle size measurements were the mean of 10 replicates and zeta potential results were the
mean of 3 replicates. Means and standard deviations were calculated using Microsoft Excel. Data were
Processes 2020, 8, 707 6 of 16
analyzed by one-way analysis of variance analysis of variance (ANOVA), followed by post-hoc Tukey’s
HSD tests using SPSS (version 22, IBM, Armonk, NY, USA). Results were considered statistically
significant if p ≤ 0.05.
3. Results
3.1. Physiochemical Characteristics of Chromium-Entrapped CS-DS Nanoparticles
The particle size of empty and chromium-entrapped CS-DS nanoparticles was the first dependent
variable assessed. Figure 2 shows how the particle size changed as the ratio of CS:DS altered. Firstly,
all samples were of submicron dimensions indicating the successful generation of nanoparticles.
The largest particles (4:1 MMW CS-Cr) were 120% bigger than the smallest particles (4:3 LMW-CS).
Secondly, as the molecular weight of chitosan increased, the particle size increased. This was seen at
a 4:1 ratio where the MMW CS particles were 19% larger than the LMW CS particles. More so, as the
volume of dextran increased, the size decreased. This was seen by there being a 32% decrease in size
when comparing 4:1 MMW CS-Cr to 4:2 MMW CS-Cr. Generally, there was a narrow size distribution
between the samples with minimal variation.
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Figure 2. Particle size of empty and c r i -e trapped CS-DS nanoparticles when using different
MWs of chitosan at various CS:DS ratios. Results are shown as mean ± standard deviation (SD) (n = 10).
Data were considered statistically different when p < 0.05. * indicates significant difference comparing
4:1 medium molecular weight (MMW) CS-Cr to MMW CS-Cr at other ratios, † indicates a significant
difference between low molecular weight (LMW) CS and MMW CS at the same ratio, ‡ indicates
a significant difference between LMW CS and LMW CS-Cr at the same ratio.
The zeta potential of chromium-entrapped particles was the second dependent variable studied.
Figure 3 illustrates how particle charge was affected by different CS:DS ratios and molecular weights
of CS. Firstly, all particles had positive zeta potentials with the charge of the most positive sample
(4:1 LMW CS-Cr) being 1.4 times higher than that of the least positive sample (4:3 MMW CS). Secondly,
the zeta potentials of the MMW CS samples were slightly lower than those produced using LMW CS.
Furthermore, the chromium-entrapped samples had larger charges compared to empty samples at
the same ratio. This was observed at 4:2 where the LMW CS-Cr sample had an 8% larger charge than
LMW CS. Generally, when comparing Figures 2 and 3 it was seen that the largest particles (produced
at a CS:DS ratio of 4:1) also had the largest zeta potentials.
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3.2. Physiochemical Characteristics of Iron-Entrapped CS-DS Nanoparticles and Submicron Particles
Iron-entrapped CS–DS nanoparticles and submicron particles were formulated, and their sizes
measured using photon correlation spectroscopy (Figure 4). First, it was observed that iron nanoparticles
were only formed at a 4:3 ratio as opposed to in Figure 2 where chromium nanoparticles were produced
at all biopolymer ratios. Similarly, when comparing Figures 2 and 4, all iron-entrapped nanoparticles
were larger than those produced using chromium. More so, both Figures indicated that as the volume
of dextran increased, the size decreased. Figure 4 also shows that as the molecular weight of chitosan
increased, the particle size increased. However, this was not the case at a ratio of 4:3 where the opposite
was true. Additionally, iron-entrapped particles were significantly larger than those which were empty
at all ratios. This was seen at 4:1 where there was a 375% increase in size when iron was added to the
LMW CS sample. Moreover, the iron-entrapped particles at a 4:1 ratio had a large size distribution as
seen by large error bars.
The zeta potential of iron encapsulated CS-DS nanoparticles and submicron particles is shown in
Figure 5. Several important observations can be made from the graph. First, the presence of iron led to
a significant decrease in charge for all samples when compared to the empty particles. This is unlike
Figure 3 wher the opposite was true when chromium was added. Moreov r, when comparing both
figures it was seen that the iron-entrapped nanoparticles h d lower zeta potenti ls at all biopolymer
ratios than those made using chromium. A similarity between Figures 3 and 5 is that samples produced
using m dium MW chitosan had slightly lower zeta potentials than those made using low MW
chitosan. This was illustrated at 4:2 where MMW CS-F had an 11% lower charge than LMW CS-Fe.
It was also the case that as the proportion of dextran increased, the charge decreased. Additionally,
when comparing Figures 4 and 5, the largest iron-entrapped particles (i.e., CS:DS 4:3) had the largest
zeta potentials. This is reflected in loading efficiency as the CS:DS 4:3 sample showed highest loading
efficiency (Table 1).
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Figure 4. Effects of CS:DS ratio, iron entrapment and chitosan molecular weight on particle size. Results
are shown as mean ± SD (n = 10). Data were considered statistically different when p < 0.05. * indicates
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difference between LMW CS and LMW CS–Fe at the same ratio, ‡ indicates a significant difference
between LMW CS-Fe and MMW CS-Fe at the same ratio.
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Figure 5. Zeta potential of iron-entrapped CS-DS nanoparticles when using different MWs of chitosan
at various CS:DS ratios. Results are shown as mean ± SD (n = 3). Data were considered statistically
different when p < 0.05. * indicates a significant difference between LMW CS and LMW CS-Fe at
the same ratio, † indicates a significant difference between LMW and MMW CS-Fe at the same ratio,
‡ indicates a significant difference between MMW CS and MMW CS-Fe at the same ratio.
3.3. Physiochemical Characteristics of Chro iu - tr e I- S Nanoparticles
The sizes of chromium-entrapped whey protein nanoparticles are depicted in Figure 6. The Figure
summarizes the variation in particle size as the volume of whey protein and CS changed. All the
particles were submicron in size, ranging from 220 nm to 503 nm and as expected, the particle size
increased with chromium entrapment. In addition, particle size increased as the volume of chitosan
increased and when the molecular weight of CS was increased. Furthermore, it was observed that as
the chitosan concentration increased from 0.1 to 0.2%, the particle size increased. This was seen at
350:1 where 0.2% LMW CS-Cr particles were 12% larger than those at LMW CS-Cr.
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T e zeta potential of chromium encapsulated WPI-CS nanoparticles is presented in Figure 7.
As shown, it was observed that all particles exhibited a negative charge and that as the volume of
chitosan increased, the charge increased. Similarly, particles produced using 0.2% CS had more positive
zeta potentials than those produced using 0.1% CS. This was seen at 350:1 where 0.2% LMW CS-Cr
was 17% more positive than LMW CS-Cr. More so, all particles produced using medium MW CS had
a slightly more negative charge than those made using LMW CS. Moreover, chromium-entrapped
samples were more positively charged than the empty formulations, similar to that seen in Figure 3.
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3.4. Physiochemical Characteristics of Iron-Entrapped WPI–CS Nanoparticles
The particle size for iron-entrapped WPI-CS nanoparticles was assessed, and the results depicted
in Figure 8. The results showed that all except one sample produced particles smaller than 1000 nm.
The largest iron encapsulated particles (50:1 MMW CS-Fe) were 4 times bigger than the smallest iron
particles (350:1 LMW CS-Fe). Chitosan inclusion at 0.2% (w/v) resulted in the formation of larger
particles, as seen at a 50:1 ratio where the particles were 1.3 times bigger than those at 0.1% LMW
CS-Fe. Additionally, iron-entrapped samples were larger than those that were empty, as illustrated at
50:1 where the MMW CS-Fe particles were 2.5 times larger than the MMW empty particles. Lastly,
as the molecular weight of CS increased, the size increased. This was seen at 350:1 where the MMW
CS-Fe particles were 33% larger than the LMW CS-Fe particles.
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Figure 8. Particle size of iron-entrapped WPI nanoparticles when using different MWs and
concentrations of chitosan at various WPI:CS ratios. Results are shown as mean ± SD (n = 10).
Data were considered statistically different when p < 0.05. * indicates a significant difference between
LMW CS-Fe and 0.2% LMW CS-Fe at the same ratio, † indicates a significant difference LMW CS-Fe
and MMW CS-Fe at the same ratio, ‡ indicates a significant difference between MMW CS and MMW
CS-Fe at the same ratio.
The zeta potential of iron-entrapped WPI nanoparticles at pH 7.5 is displayed in Figure 9. Firstly,
all the samples had a neg tive charge, with the most negativ nanocarriers being produced using
LMW CS-Fe. Secondly, as the CS concentration increased, the zeta potential became more positive.
This was observed at 350:1 where 0.2% LMW CS-Fe was one time more positive than LMW CS-Fe.
More so, the MMW CS-Fe formulations had significantly more positive charges than the LMW CS-Fe.
This differed from data shown in Figure 7, where molecular weight generally had little effect on charge.
Moreover, iron incorporation resulted in more positive zeta potentials for MMW particles but caused
the opposite effect for LMW particles compared to the empty samples. The impact on loading efficiency
can be clearly seen when varying the WPI:CS ratio (Table 3).
3.5. Caco-2 Cell Iron Permeability Studies
Permeability studies of the WPI-CS-Fe nanoparticles were undertaken using Caco-2 cells and
the results shown in Figure 10. There was a large variation in iron uptake between the samples.
The 350:1 LMW CS-Fe sample produced the highest iron absorption with 64% more ferritin being
absorbed than from the ferrous sulfate reference. Similarly, the 175:1 LMW CS-Fe sample had an 8.7%
higher iron absorption compared to the reference. In contrast, the sample produced using medium
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MW CS had the lowest iron absorption. Unexpectedly, the sample that contained a higher volume of
chitosan (125:1 LMW CS-Fe) performed worse than the standard (a 7.7% decrease in absorption).
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4. Discussion
Particle size was measured, as it can affect drug release and absorption. As seen in previous
studies [7,8], smaller particles have larger surface area to volume ratios, leading to improvement in
intestinal drug permeability and thus an increase in absorption. The intestinal clearance mechanisms
are also minimized and this prolongs the residence time of the formulation [9]. The zeta potential is
an important assessment of formulation stability and the extent to which particles permeate through
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membranes. Collectively, these factors play an integral role in the absorption of iron and chromium
and can be tailored to give patients the most benefit from supplement therapies.
4.1. Properties of CS–DS Nanoparticles
Chitosan and dextran nanoparticles were produced via complex coacervation where the negatively
charged sulfate groups of dextran interacted with the positively charge amino groups of chitosan
(Figure 1). The properties of the particles were altered based on the biopolymer ratios used. Previous
observations demonstrated that increasing dextran ratio in the system decreased particle size [18].
This was in accordance with Figures 2 and 4 where there were inverse relationships between dextran
ratio and size. A reason for this is due to the differing molecular weights of the two biopolymers [18].
In this study chitosan had a molecular weight of 50/190 kDa whilst that of dextran was 15.6 kDa.
When chitosan ratio was high, there was repulsion between its cationic groups, leading to more cross
linking sites becoming available to form hydrogen bonding with water [18]. This caused water to
penetrate into the polymer matrices, causing the particles to swell and increase in size. However,
when the ratio of dextran was lowered into the system, sites for electrostatic interactions were fully
occupied with chitosan, leading to less hydration occurring [22]. These interactions also caused
a decrease in the positive charge of chitosan, causing folding to occur and the formation of smaller
particles with lower zeta potentials (Figures 2 and 3). The higher levels of dextran also acted as
a colloidal protectant, causing the retardation of inter/intra molecular interactions as a result of steric
hindrance (1). This prevented aggregation occurring and could be the reason that smaller particles were
formed at higher dextran volumes. As seen in other studies [28], particles made with MMW CS were
larger than those produced with low MW CS. An explanation for this is that MMW CS contained longer
chain meaning that the tertiary amine groups were harder to protonate. This meant that there were less
electrostatic interactions between CS and DS, leading to the formation of larger particles [28]. The iron
nanoparticles were generally considerably larger than those made using chromium. A reason for this
is because rapid aggregation of the iron-entrapped particles occurred, as observed by the large error
bars in Figure 4. Other studies have explored the use of polyethylene glycol-40 to improve colloidal
stability [29]. However, this approach may affect drug release kinetics from the colloidal system.
4.2. Properties of WPI-CS Nanoparticles
Proteins contain both acidic and basic amino acids, giving them the unique ability to form
nanoparticles with polysaccharides such as chitosan in certain environmental conditions. Whey protein
was heat treated to 85 ◦C in order to denature the protein secondary structures and improve
their solubility. When the pH was adjusted to 7.5 the secondary structures reorganized and
unfolding occurred, leading to more cross linking sites becoming available [30]. There were also
more thiol-disulfide exchange reactions occurring which caused further particle formation and the
discouragement of aggregation. More so, chitosan and β-lactoglobulin had opposite charges at pH 7.5
causing electrostatic attraction and complexation to occur. This was clearly seen there was inverse
correlation between the pH and size of formed nanoparticles (Figure 11). It is interesting to observe
the impact of pH on size of the nanoparticles as chitosan is only soluble at lower pH values; however,
the size of the particles has decreased at higher pH. This indicates favorable interactions with whey
protein chains preventing precipitation of chitosan as separate colloidal particles.
Visual inspection of iron containing nanoparticles revealed stability dependent on WPI/CS ratio.
As can be seen, there was a color change for samples that contained lower ratio of WPI/CS. WPI/CS
350:1 had similar color while the WPI/CS 50:1 showed noticeable color change. This is highlighted in
Figure 12 where 50:1 LMW CS-Fe and 125:1 LMW CS-Fe changed color from orange to dark brown.
As shown above, all samples contained similar amount of ascorbic acid which acts as antioxidant.
Hence, this color change cannot be attributed to variable oxidation activity. Denaturing of whey
protein isolate can also happen due to oxidative stress [31], which may contribute to this color change.
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This also highlights that using WPI/CS 350:1 has produced particles with optimum stability and
encapsulation efficiency.
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Figure 12. Physical stability of iron-entrapped PI-CS nanosuspensions (a) 10 min and (b) 10 days
post-production. From left to right—50:1 LMW CS-Fe, 125:1 LMW CS-Fe, 350:1 LMW CS-Fe.
Larger particles wer formed when the molecular weight of chitosan incre s ( 8).
This agreed with previous w rk and occurred because the MMW CS had a lower aqueous solubility,
meaning that aggregation was more likely to occur [32]. Conversely, LMW CS solution was less viscous,
meaning that kinetic energy barrier for nanoparticle aggregation is enhanced which can promote
formation of smaller nanoparticles. The same explanation was used to explain why the particle size
increased as the concentration of chitosan increased; 0.2% CS was more viscous and less soluble,
leading to inefficient particle formation. Furthermore, the zeta potential increased with increasing
chitosan concentration (Figures 7 and 9). This was because 0.2% chitosan imparted a more positive
charge on the particle surfaces due to its positively charged amino groups [8]. Similarly, the particle
size of iron and chromium-entrapped particles increased with an increased volume of CS (Figures 6
and 8). Presence of chitosan chains and especially at the surface conferred the nanoparticles sufficient
stability and promoted efficient encapsulation. This led to more chromium and iron being entrapped
into particles, causing their size to increase. Moreover, when chromium and iron were added into the
formulations, the sizes increased compared to empty samples. This is because chromium can adsorb
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to chitosan chains, leading to enhanced entrapment [33]. More so, the MMW CS-Fe particles had
significantly higher zeta potentials than those produced with LMW CS-Fe (Figure 9). This was because
MMW CS had a larger number of positively charged amine groups due to its longer chain lengths.
4.3. Iron Absorption in Caco-2 Cells
Caco-2 cells were used because they resemble intestinal enterocytes and the assay investigates the
intestinal permeability of orally absorbed drugs [34]. As seen in Figure 10, both the 350:1 LMW CS and
175:1 CS samples caused higher iron absorptions compared to the ferrous sulfate standard. This was
in agreement with the previous work which stated that ascorbic acid augments iron absorption [8].
Another reason for the enhancement is because chitosan was used in the formulations. Chitosan has
mucoadhesive properties and as a result is a permeation enhancer which can cause the restructuring
of tight junction-associated proteins [35]. Moreover, the low MW CS samples caused higher ferritin
absorptions than the MMW CS sample because the particles exhibited smaller size. This meant they
could permeate into the cells and the iron could interact with the divalent metal transporters [36].
The size of formed particles was submicron was in the nanometer range (Figure 13). This agreed with
the size analysis results and confirmed that the formed nanoparticles exhibited a size range suitable
for oral drug delivery. Due to challenges with the analysis of chromium, which requires the use
of atomic absorption spectroscopy, our future work will focus on the analysis and optimization of
chromium-loaded carriers.
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5. Conclusions
This study reports the formation of novel iron and chromium-loaded nanoparticles using different
biopolymers. The properties of the samples were characterized, culminating in an iron absorption assay.
It was seen that increasing the chitosan volume and concentration significantly increased the particle
size and zeta potential, whilst the opposite was true for dextran. Permeability studies showed that
iron uptake was strongly correlated to particle size and that two samples produced higher absorptions
than ferrous sulfate. The results demonstrate the ability of the nanoparticles to act as novel delivery
vehicles for supplementary therapy in the future.
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